BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31193613)

  • 1. Prophylactic Intravenous Hydration to Protect Renal Function From Intravascular Iodinated Contrast Material (AMACING): Long-term Results of a Prospective, Randomised, Controlled Trial.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    EClinicalMedicine; 2018; 4-5():109-116. PubMed ID: 31193613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
    Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
    Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on clinical practice of updated guidelines on iodinated contrast material: CINART.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van der Molen AJ; van Ommen GV; Wildberger JE
    Eur Radiol; 2020 Jul; 30(7):4005-4013. PubMed ID: 32107605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of withholding standard prophylaxis in patients with moderate chronic kidney disease.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen GV; Wildberger JE
    Eur Radiol; 2023 Jan; 33(1):627-632. PubMed ID: 35763097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic hydration to protect renal function from intravascular iodinated contrast material.
    Baheti AD; Jankharia B
    Natl Med J India; 2017; 30(5):272-273. PubMed ID: 29916428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis in High-Risk Patients With eGFR < 30 mL/min/1.73 m2: Get the Balance Right.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; Theunissen RA; van Ommen V; Wildberger JE
    Invest Radiol; 2019 Sep; 54(9):580-588. PubMed ID: 31033672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Contrast Acute Kidney Injury and Intravenous Prophylactic Hydration: An Update.
    Nijssen EC; Rennenberg R; Nelemans P; van Ommen V; Wildberger JE
    Rofo; 2021 Feb; 193(2):151-159. PubMed ID: 33327033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of prophylactic hydration versus no hydration on contrast-induced acute kidney injury.
    Jiang Y; Chen M; Zhang Y; Zhang N; Yang H; Yao J; Zhou Y
    Coron Artery Dis; 2017 Dec; 28(8):649-657. PubMed ID: 28692484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous versus oral hydration to reduce the risk of postcontrast acute kidney injury after intravenous contrast-enhanced CT in patients with severe chronic kidney disease (ENRICH): a study protocol for a single-centre, parallel-group, open-labelled non-inferiority randomised controlled trial in Denmark.
    Ravn EJ; Hasific S; Thomassen M; Hjortebjerg R; Bach Laursen K; Diederichsen A; Bistrup C; Øvrehus KA
    BMJ Open; 2023 Sep; 13(9):e074057. PubMed ID: 37699636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial.
    Bell RM; Rear R; Cunningham J; Dawnay A; Yellon DM
    Clin Res Cardiol; 2014 Mar; 103(3):203-9. PubMed ID: 24292557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
    Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
    Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of contrast-induced nephropathy after a computed tomography scan.
    Barrios López A; García Martínez F; Rodríguez JI; Montero-San-Martín B; Gómez Rioja R; Diez J; Martín-Hervás C
    Radiologia (Engl Ed); 2021; 63(4):307-313. PubMed ID: 34246421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease.
    Kroneberger C; Enzweiler CN; Schmidt-Lucke A; Rückert RI; Teichgräber U; Franiel T
    Acta Radiol Open; 2015 Jun; 4(6):2058460115583034. PubMed ID: 26346218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
    Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?
    Rudnick MR; Leonberg-Yoo AK; Litt HI; Cohen RM; Hilton S; Reese PP
    Am J Kidney Dis; 2020 Jan; 75(1):105-113. PubMed ID: 31473019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CIN Study).
    Schilcher G; Ribitsch W; Otto R; Portugaller RH; Quehenberger F; Truschnig-Wilders M; Zweiker R; Stiegler P; Brodmann M; Weinhandl K; Horina JH
    BMC Nephrol; 2011 Aug; 12():39. PubMed ID: 21849080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
    Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
    Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.